FreshLeaf Analytics News

TGA warns medical cannabis industry about advertising regulation breaches The Therapeutic Goods Administration (TGA), Australia’s health products regulator, has issued a stern warning to the medical cannabis industry that it will soon be ramping up its investigations into alleged breaches of the advertising regulations. This will dovetail with the TGA’s ongoing investigations into product quality...Read More

The Export Control Legislation Amendment (Certification of Narcotic Exports) Bill 2020, which passed the Senate on June 17, will allow the Commonwealth Department of Agriculture, Water and the Environment to issue phytosanitary certificates for the export of medicinal cannabis and hemp products. This bill will remove an unintended regulatory barrier which has been hampering some...Read More

A CBD product might soon be available and subsidised on the Pharmaceutical Benefits Scheme   Families of children with severe drug-resistant epilepsy might soon be able to access a subsidised medicinal cannabis product in Australia.  In January 2020 the Department of Health, in their submission to the Senate Inquiry into barriers to patient access to...Read More

NZ recreational cannabis bill released – prioritises social good over profits New Zealanders will go to the polls on September 19 to vote for their federal government as well as two contentious referenda: voluntary assisted dying and recreational cannabis. The full recreational cannabis bill is now published and the government has provided an accompanying plain-English...Read More

Australian government proposes CBD be made available for retail sale Today the Therapeutic Goods Administration released the Department of Health-initiated proposal to make low-dose CBD oil available for sale in pharmacies as a Schedule 3 drug. The proposed changes would allow the sale of pure CBD oil  (with 2% or less other cannabinoids) to adults...Read More

Australian Senate Committee tables recommendations from inquiry into barriers to medical cannabis The Community Affairs and References Committee tabled their report today (25/3/20) on the inquiry into barriers to medical cannabis patient access in Australia.  FreshLeaf has covered this inquiry extensively and attended the public hearings, so if you’re interested in the recent history of...Read More

What does a global recession mean for the cannabis industry? COVID-19 is wreaking havoc on the global economy. And there are genuine concerns about a prolonged economic downturn, unlike any other in recent memory. People are worried about their health and for their families, as well as their businesses and jobs. The performance and survival...Read More

Medical cannabis quality crack-down   The Therapeutic Goods Administration (TGA) has announced it will be ramping up the number of quality audits it conducts on imported medical cannabis products. This will include analytical testing to assess compliance with TGO93, the quality standard for cannabis products.  TGO93 requires products to have acceptable levels of pesticides, heavy...Read More

We attended the ODC’s consultation session on proposed medical cannabis license changes so you didn’t have to The Office of Drug Control (ODC) held consultation sessions in three capital cities over the last week seeking feedback on their proposed changes to Australia’s commercial medical cannabis licensing system. FreshLeaf attended the Sydney workshop on February 3rd...Read More